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Abstract
Objective
The aim of this study was to identify early proteomic biomarkers of spontaneous preterm
delivery (PTD) in mid-trimester amniotic fluid from asymptomatic women.
Methods
This is a case-cohort study. Amniotic fluid from mid-trimester genetic amniocentesis (14–19
weeks of gestation) was collected from 2008 to 2011. The analysis was conducted in 24
healthy women with subsequent spontaneous PTD (cases) and 40 randomly selected
healthy women delivering at term (controls). An exploratory phase with proteomics analysis
of pooled samples was followed by a verification phase with ELISA of individual case and
control samples.
Results
The median (interquartile range (IQR: 25th; 75th percentiles) gestational age at delivery was
35+5 (33+6–36+6) weeks in women with spontaneous PTD and 40+0 (39+1–40+5) weeks
in women who delivered at term. In the exploratory phase, the most pronounced differences
were found in C-reactive protein (CRP) levels, that were approximately two-fold higher in
the pooled case samples than in the pooled control samples. However, we could not verify
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these differences with ELISA. The median (25th; 75th IQR) CRP level was 95.2 ng/mL (64.3;
163.5) in women with spontaneous PTD and 86.0 ng/mL (51.2; 145.8) in women delivering
at term (p = 0.37; t-test).
Conclusions
Proteomic analysis with mass spectrometry of mid-trimester amniotic fluid suggests CRP
as a potential marker of spontaneous preterm delivery, but this prognostic potential was not
verified with ELISA.
Introduction
Preterm delivery (PTD) is a current global concern in obstetric and neonatal care [1, 2]. It is
related to short- and long-term morbidity in neonates [3] and is a leading cause of child death
worldwide. Approximately two-thirds of PTDs are spontaneous [4]. The etiology behind spon-
taneous PTD is complex, and understanding of the sequence and timing of events preceding
the condition is incomplete [5].
Proteomics, one of the most promising platforms for biomarker detection, provides insight
into the basic biological mechanisms involved in a condition. It constitutes an alternative unbi-
ased approach, compared to the widely used hypothesis-based biomarker discovery approach
[6, 7]. Previous studies have explored the maternal, fetal [8–13] and amniotic fluid proteomes
and their associations with intra-amniotic inflammation, intra-amniotic infection and PTD in
women with preterm labor or preterm prelabor rupture of membranes [8, 10, 11, 14–21]. How-
ever, there are only a few published studies exploring the potential of proteomics early in preg-
nancy, before onset of symptoms. To the best of our knowledge, Fotopoulou et al. [15] are the
only researchers who have investigated the protein composition in mid-trimester amniotic
fluid in relation to spontaneous PTD, using mass spectrometry profiling. However, their results
have not been verified, as is considered mandatory for proteomic analysis [22], representing a
considerable limitation.
Due to the complexity and incompletely identified pathophysiological pathways of sponta-
neous PTD, clinical applications of proteomic technology are still in the early stages [5]. More-
over, the translation of proteomic knowledge into the clinical setting requires verification with
an easier, rapid, cost-effective method.
Identification of early prognostic or diagnostic biomarkers, before onset of clinical symp-
toms, is important. The main aim of this study was therefore to explore potential early bio-
markers for spontaneous PTD during the mid-trimester of pregnancy in an exploratory
proteomics phase with a pooled sample strategy, utilizing liquid chromatography-tandem mass
spectrometry (LC-MS/MS). The second aim was to verify the difference in candidate protein
levels found between cases and controls, using ELISA in individual samples from the same
cohort.
Materials and Methods
Study design
This study was a case-cohort study of women, aged over 18, who underwent a mid-trimester
transabdominal genetic amniocentesis at 14–19 weeks of gestation in a viable singleton preg-
nancy. Amniocentesis indications were advanced maternal age, anxiety, abnormal first-
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trimester combined screening or family history of chromosomal abnormalities or genetic dis-
eases. Age under 18 years, multiple pregnancy, positive HIV or hepatitis B test and known or
suspected fetal malformation were exclusion criteria. Women who could not understand the
written and oral information in Swedish, who declined participation or from whom insufficient
amniotic fluid was retrieved at amniocentesis were also excluded.
After medical review, women with chronic diseases (e.g. severe rheumatism, hypo- or
hyperthyroidism, severe asthma, diabetes mellitus, hypertension, multiple sclerosis, hereditary
chromosomal defects, vitamin D deficiency and severe neurological disorders) were excluded
from analysis.
Women with a subsequent spontaneous PTD were compared with women who delivered at
term. For the sake of homogeneity, the term delivery group was limited to women giving birth
at gestational weeks 38+0 to 41+6, among whom a random selection was made in order to con-
stitute the control group. Medical records were scrutinized at inclusion and after delivery.
Sample collection
An additional 3 mL of amniotic fluid was collected during mid-trimester genetic transabdom-
inal amniocentesis and immediately stored at 4-8°C. The samples were centrifuged for 20 min-
utes at 12°000 g, at 4°C. The supernatant was separated from the pellet and divided into
aliquots that were frozen and stored at -80°C. All samples were handled according to a stan-
dardized protocol at the same laboratory.
Exploratory proteomics phase: sample preparation and LC-MS/MS
analysis
For the exploratory proteomic analysis, pooled amniotic fluid supernatant samples from cases
and controls were prepared according to the approach reported by Tambor et al. [23]. Briefly,
the samples were supplemented with protease inhibitors and filtered. An equal amount of pro-
tein was taken from each sample to create a pooled representative control sample and a repre-
sentative case sample; both were created in duplicate. The most abundant proteins in the
samples were removed using a MARS Hu-14 immunoaffinity column (Agilent, Palo Alto, CA).
The proteins were then reduced with tris (2-carboxyethyl) phosphine hydrochloride and the
thiol groups were blocked with methyl methane thiosulfonate. Proteins were digested with
trypsin at 37°C overnight. The peptides in the representative control samples were labeled with
isobaric tags for relative and absolute quantification using iTRAQ 114 and 116 tags, while rep-
resentative case samples were labeled with iTRAQ 115 and 117 tags (AB Sciex, Foster City,
CA). High-pH reversed-phase chromatography was then employed to fractionate the peptides
into six 2-minute fractions. An UltiMate 3000 RSLCnano system hyphenated to a Q-Exactive
mass spectrometer (Thermo Scientific, Bremen, Germany) was used for protein identification
and quantification, using the full MS/Top10 experimental setup. The recorded HCD fragmen-
tation spectra were evaluated in Proteome Discoverer software (Thermo Scientific), using
MASCOT (Matrix Science, London, UK) against the human UniProt database. When it came
to quantification, only proteins up to 1% FDR threshold were reported and only proteins quan-
tified with at least three peptides were evaluated. The most significantly regulated proteins
were found by global ranking method [24]. For both duplicates, 25 proteins were evaluated
from the top and from the bottom of list of proteins ranked based on the relative quantitative
change (Fig 1). Further specific details regarding the exploratory proteomics phase can be
found in the supporting materials and methods (S1 File).
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Verification of amniotic fluid CRP levels by ELISA immunoassay
Amniotic fluid C-reactive protein (CRP) levels were determined in individual case samples and
control samples with commercially available ELISA kits (Quantikine ELISA, R & D Systems,
Minneapolis, MN). All samples were initially diluted 1/100, but if the subsequent absorbance
was below the detection limit for the assay, a 1/10 dilution was used instead. The detection
Fig 1. Graphic presentation of the methodology of sample processing and LC-MS/MS analysis of pooled case and control
samples.
doi:10.1371/journal.pone.0155164.g001
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range of the assay was 0.78–50 ng/mL, but dilutions accommodated a practical detection range
of 7.8–5000 ng/mL. All of the samples were run in duplicate. The interassay coefficient of varia-
tion (CV) was<15%, and the intraassay CV was<5% on all three plates. If duplicates varied
more than 15%, the samples were rerun. The resulting absorbance was read at 450 nm (Multis-
kan FC Microplate Photometer).
Ethics statement
This study was approved by the Central Ethical Review Board at the University of Gothenburg,
Sweden (Dnr. Ö 639–03, T 318–08, T 694–11, T 958–11). Written informed consent was
obtained from all participants.
Statistical analyses
Continuous variables were compared using a nonparametric Mann-Whitney U Test and pre-
sented as median and interquartile range (IQR: 25th; 75th percentiles). Categorical variables
were compared using Fisher’s Exact Test and presented as the number (%). Differences were
considered statistically significant at p< 0.05 using a two-sided alternative hypothesis. All sta-
tistical analyses were performed with SPSS 20.0 for Windows XP OS (SPSS Inc., USA).
Results
Characteristics of the entire study group
From September 2008 to September 2011, 1546 women underwent mid-trimester amniocente-
sis at Sahlgrenska University Hospital/Östra, Gothenburg, Sweden. Of this population, 426
women did not fulfill the strict inclusion criteria and 495 were excluded, the majority of whom
because they declined participation. An additional 18 women were excluded from analysis;
twelve requested a termination of pregnancy due to chromosomal abnormality and six were
lost to follow-up.
The remaining women (n = 607) were included in the study. Their medical records were
scrutinized at inclusion and after delivery. PTD occurred in 6.3% (38/607), of which 4.8% (29/
607) were spontaneous PTD and 1.5% (9/607) were iatrogenic PTD. Of the group with sponta-
neous PTD, five women were excluded due to hypothyroidism, severe asthma, bicornuate
uterus, type 1 diabetes, translocation and/or discolored amniotic fluid at sampling. Therefore,
the remaining women with spontaneous PTD (n = 24) constitute the cases in this study.
Of the 569 women who delivered at37 gestational weeks, 381 were healthy and gave birth
at gestational week 38+0 to 41+6. Forty were randomly selected and they constituted the final
control group in this study (Fig 2).
The respective maternal and neonatal characteristics of the spontaneous PTD and term
delivery groups are presented in Table 1. There were no significant differences between the
groups, except for the obvious difference in birth weight.
Exploratory proteomics phase: LC-MS/MS analysis
In the exploratory phase, a total of 77411 spectra were searched, and an amino sequence was
assigned in 24641 spectra (1% false discovery rate (FDR)), resulting in the identification of
7267 distinct peptides and 1088 protein groups. Of the protein groups, 594 were quantified
with at least three peptides. Of these, 17 proteins were reproducibly upregulated (FDR 0.029)
and 19 proteins were downregulated (FDR 0.026), as shown in S1 and S2 Tables. Five upregu-
lated and five downregulated proteins were among top 10 dysregulated proteins independently
on the direction of the change (Table 2). The most pronounced difference between levels in the
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pooled control and pooled case samples was found in the case of CRP (P02741, CRP), which
was selected for further verification with ELISA.
Verification of amniotic fluid CRP level difference from the exploratory
phase
In the exploratory proteomics analysis, CRP levels were approximately two-fold higher in cases
than in controls in both duplicates. We attempted to verify this difference in the same women,
but with an individual ELISA analysis of each case and control sample. The median (IQR: 25th;
75th percentiles) CRP level (ng/mL) in the spontaneous PTD group was 95.2 (64.3; 163.5) com-
pared to 86.0 (51.2; 145.8) in the term delivery group, a difference that was not significant
(p = 0.37) (Fig 3).
Discussion
The exploratory proteomics phase of this study, analyzing pooled samples from mid-trimester
amniotic fluid in asymptomatic women, revealed rather few dysregulated proteins. CRP was
selected for verification since it had the most pronounced difference in levels between the con-
trol and case groups. Furthermore, it was the subject of previous publications and was readily
available as a commercial human ELISA test. However, the case-control CRP level difference
Fig 2. Flow chart showing selection of study participants.
doi:10.1371/journal.pone.0155164.g002
Mid-Trimester Amniotic Fluid Proteome Does Not Predict Spontaneous Preterm Delivery
PLOS ONE | DOI:10.1371/journal.pone.0155164 May 23, 2016 6 / 11
we initially found with proteomics, and the related prognostic potential, was not verified on
subsequent individual analysis with ELISA.
CRP is a very well described marker of systemic inflammation [25] and it is associated with
both PTD and preterm prelabor rupture of membranes [26, 27]. Several studies have previously
performed targeted analyses of CRP in mid-trimester amniotic fluid [26, 28–31], with contra-
dictory results. While three studies [28, 29, 31] did not find any significant differences between
Table 1. Maternal and neonatal characteristics in the group of womenwith spontaneous preterm delivery and the group of women with term
delivery.
Variable Spontaneous preterm delivery (n = 24) Term delivery (n = 40) p
Gestational age at delivery (weeks+days) 35+5 (33+6–36+6) 40+0 (39+1–40+5)
Maternal age at sampling (years) 37 (36–40) 36 (35–38) 0.69
Nulliparous 9 (37.5%) 12 (30.0%) 0.59
IVF 4 (16.7%) 1 (2.5%) 0.06
Maternal BMI at ﬁrst prenatal visit 24.6 (23.6–26.9) 23.5 (21.2–26.3) 0.23
Smoking at ﬁrst prenatal visit 2 (8.3%) 2 (5.0%) 0.63
Previous preterm delivery 3 (12.5%) 1 (2.5%) 0.14
Gestational age at sampling (weeks+days) 15+5 (15+2–16+3) 15+5 (15+2–16+2) 0.69
Mode of delivery
Vaginal delivery 21 (87.5%) 28 (70.0%) 0.14
Caesarean section 3 (12.5%) 8 (20.0%) 0.51
Vacuum extraction 0 (0%) 4 (10.0%) 0.29
Birth weight (grams) 2505 (2378–2848) 3530 (3215–3713) <0.0001
Gender 0.18
Male 9 (37.5%) 21 (52.5%)
Female 15 (62.5%) 19 (47.5%)
Apgar score < 7 at 5 min 0 (0%) 1 (2.6%) 0.62
Continuous variables were compared using a nonparametric Mann-Whitney U Test and presented as the median (interquartile range). Categorical
variables were compared using Fisher’s Exact Test and presented as the number (%).
doi:10.1371/journal.pone.0155164.t001
Table 2. The ten most dysregulated proteins in both duplicates (115/114 and 117/116) from the exploratory proteomics analysis, where 115 and
117 represent the channels for the cases and 114 and 116 represent the channels for the controls.
Prot. Acc. # Gene Description 115/114 117/116
P02741 CRP C-reactive protein 2.27 2.30
P60174 TPI1 Triosephosphate isomerase 2.26 1.95
A8K7I4 CLCA1 Calcium-activated chloride channel regulator 1 1.75 1.98
P40925 MDH1 Malate dehydrogenase, cytoplasmic 1.86 1.63
P01037 CST1 Cystatin-SN 1.46 1.51
P02042 HBD Hemoglobin subunit delta 0.56 0.52
P69905 HBA1 Hemoglobin subunit alpha 0.60 0.51
P68871 HBB Hemoglobin subunit beta 0.61 0.52
P09466 PAEP Glycodelin 0.61 0.59
P49913 CAMP Cathelicidin antimicrobial peptide 0.65 0.71
As reported in the table, ﬁve upregulated and ﬁve downregulated proteins were among top 10 dysregulated proteins independently on the direction of the
change. The level of CRP was roughly two-fold higher in the pooled samples from cases (115, 117), compared to the pooled samples from controls (114,
116).
doi:10.1371/journal.pone.0155164.t002
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amniotic fluid CRP levels in cases of spontaneous PTD and term deliveries, Ozer et al. [30] and
Ghezzi et al. [26] did find significant differences. These conflicting results highlight our effort
to analyze this protein using a different but complementary approach.
The mid-trimester amniotic fluid proteome has been explored in relation to spontaneous
PTD in twins [32] but there is, to our knowledge, only one published study exploring mid-tri-
mester amniotic fluid as a predictor of spontaneous PTD in singletons. Fotopoulou et al. [15]
investigated a small group of women with both spontaneous PTD and term deliveries. Using a
combination of mass spectrometry and different solid-phase chromatography protein chips,
they identified seven clusters that differed significantly when women with a subsequent sponta-
neous PTD were compared with women who delivered at term. However, the individual pro-
teins/peptides could not be identified by SELDI TOF analysis.
A major strength of our study is the verification phase, otherwise frequently neglected. The
standardized protocol for sample handling and the strict selection criteria for the case and con-
trol groups are additional strengths. Furthermore, this study had a relatively large cohort of
healthy, asymptomatic women with subsequent spontaneous PTD and a very low lost-to-fol-
low-up rate.
An important limitation of the study was that one single biomarker (CRP) was selected for
further verification. We refrained from considering other potential biomarkers that had, in
contrast to CRP, not been the objects of previous published mid-trimester studies. A pooling
strategy provides an initial proteomic evaluation, albeit not as expensive or time-consuming as
proteomic analysis of each and every individual sample. However, the pooled sample strategy
inevitably has certain limitations. One such limitation is the absence of estimates of individual
variability, required to facilitate significance testing. We hypothesized that the discrepancy
between the exploratory phase and the verification stage might have been caused by the fact
that some samples may have contained extremely low/high analyte levels (outliers) and may
thus have shifted levels in the entire pool. The key prerequisite if samples are pooled is thus
results verification in individual samples with an alternative method, which we attempted
using ELISA. Finally, another limitation of this study might be that the spontaneous PTD
group consisted of women with both preterm labor and preterm prelabor rupture of mem-
branes; the respective phenotypes may differ somewhat.
Fig 3. A two-column scatter graph of median (IQR: 25th; 75th percentiles) amniotic fluid CRP levels in
the groups.
doi:10.1371/journal.pone.0155164.g003
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Conclusions
The exploratory proteomic phase of the experiment revealed six dysregulated proteins, of
which CRP levels were approximately two-fold higher among women with spontaneous PTD,
compared to controls. However, when individual cases and controls were examined with
ELISA, there was no significant difference in CRP levels between the case and control groups.
This finding is interesting in light of how extensively this test is used, and confirms the current
ambiguity concerning its status. Further proteomics studies are needed, on individual samples
and with similar strict criteria for the groups as in this study.
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